No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
Yixintang Pharmaceutical Group Co., Ltd. is a prominent Chinese enterprise primarily managing an extensive network of pharmacies nationwide. The company's operations also encompass the production and retail of a diverse array of items, including raw medicinal ingredients, traditional Chinese herbal medicines, and various health and dietary supplements. Furthermore, it actively participates in pharmaceutical distribution. By January 31, 2020, its retail footprint spanned 7,205 outlets across numerous provinces and municipalities, such as Yunnan, Guizhou, Guangxi, Sichuan, Shanxi, Chongqing, Tianjin, Shanghai, and Qiong. Complementing its brick-and-mortar presence, Yixintang also conducts online sales. Established in 2000 with its headquarters in Kunming, China, the company adopted its current name, Yixintang Pharmaceutical Group Co., Ltd., in June 2019, having previously been called Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd.
www.hx8886.comNo one on the platform currently holds 002727.SZ.
No tracked institution reports a position in 002727.SZ as of their last filing.
No one on the platform has traded 002727.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 3.7% | — | — | — | ||
| Rev. Growth % | -3.7% | 6.5% | ||||
| Profit Margin % | 1.5% | 3.5% | 4.6% | |||
| Free Cash Flow Margin % | 7.8% | |||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $17.5B | +2.1% | $0.77 | $0.69–$0.86 | — | 2 |
| 2027 | $18.6B | +5.8% | $0.92 | $0.74–$1.09 | — | 2 |
| 2028 | $19.9B | +7.0% | $1.09 | $1.02–$1.14 | — | 1 |
| 2029 | $24.3B | +22.2% | $1.91 | $1.77–$1.99 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 1 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-26 | $0.29 | $0.14 | -50.4% |
| 2026-04-28 | $0.02 | $-0.01 | -147.0% |
| 2026-04-28 | $0.27 | $0.30 | +11.1% |
| 2025-10-30 | $0.28 | $0.03 | -88.4% |
| 2025-04-27 | $0.40 | $0.27 | -32.5% |
| 2025-04-27 | $0.13 | $-0.30 | -343.7% |
| 2024-10-30 | $0.27 | $0.02 | -92.6% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 002727.SZYixintang Pharmaceutical Group Co., Ltd. | $10.79 | -1.10% | $6.3B | — |
| 002038.SZBeijing SL Pharmaceutical Co., Ltd. | $5.57 | +0.00% | $5.7B | — |
| 002390.SZGuizhou Xinbang Pharmaceutical Co., Ltd. | $2.91 | +0.00% | $5.7B | — |
| 002940.SZZhejiang AngLiKang Pharmaceutical CO.,LTD. | $22.73 | +0.04% | $4.5B | — |
| 300206.SZEdan Instruments, Inc. |
| $11.08 |
| +1.09% |
| $6.4B |
| — |
| 300406.SZBeijing Strong Biotechnologies, Inc. | $11.18 | -0.27% | $6.6B | — |
| 600195.SSChina Animal Husbandry Industry Co., Ltd. | $6.65 | -0.89% | $6.8B | — |
Source: Financial Modeling Prep · peers by sector/industry